Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ascorbic Acid for Basal Cell Carcinoma
NCT04279535Phase 1Completed
- Sponsor
- Center for Biomedical Research
- Start
- Mar 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ascorbic acid in basal cell carcinoma (BCC) (2 arms), sponsored by Center for Biomedical Research. Primary endpoint: Lesion Resolution at 8 weeks. Started Mar 2018; status: completed.
02
Drugs
ascorbic acid
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT04279535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04279535.